CompletedNot applicableNCT00096538
Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma
Studying HIV-associated cancer
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Principal Investigator
- Susan E. Krown, MDMemorial Sloan Kettering Cancer Center
- Intervention
- valganciclovir(drug)
- Enrollment
- 6 enrolled
- Eligibility
- 18-120 years · All sexes
- Timeline
- 2004 – 2008
Study locations (3)
- Memorial Sloan - Kettering Cancer Center, New York, New York, United States
- New York Weill Cornell Cancer Center at Cornell University, New York, New York, United States
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
Collaborators
National Cancer Institute (NCI) · New York Presbyterian Hospital · Weill Medical College of Cornell University · University of North Carolina, Chapel Hill
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00096538 on ClinicalTrials.govOther trials for HIV-associated cancer
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07308886Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)National Cancer Institute (NCI)
- RECRUITINGNANCT05561595Transdiagnostic Intervention to Reduce Internalized Health-Related StigmaUniversity of Florida
- RECRUITINGPHASE1, PHASE2NCT06343311T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)Estrella Biopharma, Inc.
- ACTIVE NOT RECRUITINGNCT06480773Kaposi Sarcoma Chemotherapy and Research (KS-CARE)UNC Lineberger Comprehensive Cancer Center
- RECRUITINGPHASE1NCT04902443Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIVNational Cancer Institute (NCI)
- RECRUITINGPHASE1, PHASE2NCT04941274Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi SarcomaNational Cancer Institute (NCI)